The Division of Digital Psychiatry team at Beth Israel.
January 31, 2020
Walking down the halls of the research wing at Beth Israel Deaconess in Boston, it’s hard to miss the bright orange biohazard warnings on the door of nearly every lab — except one. Formed in 2018, the Division of Digital Psychiatry is focused on technology’s role in improving mental health care.
Led by Dr. John Torous, the division’s first digital tool, dubbed mindLamp, is focused on examining "...
August 27, 2019
This morning FIGUR8, a new digital platform designed to measure and track body movements as a biomarker, launched with a boost of $7.5 million seed funding. The funding was led by P5 Health Ventures with participation from E14 Fund.
Co-created by researchers at MIT Media Lab and Massachusetts General Hospital Sports Science Lab, the technology was developed with the goal of creating a baseline...
April 18, 2019
While smartphones are yet to replace the eyes as the window into the soul, there is a budding conversation around the technology serving as window into an individual’s wellbeing. Biomarkers from smartphones, such as GPS, usage and physical activity, are now being used by providers and employers as an indicator of mental health.
Patients' willingness to share passive smartphone data varies...
Dr. Daniel Karlin, Greg Plante, Dr. Stephen Wicks, Dr. Zachary Beattie, and Dr. Mahesh Fuldeore
June 8, 2018
Pharma companies are increasingly embracing the use of wearables and other connected devices to streamline and improve data collection in clinical trials. But for all the advantages these devices might have, there also challenges — especially when it comes to data standardization.
This week at BIO 2018, Dr. Daniel Karlin, Pfizer’s head of clinical, informatics, regulatory strategy, digital...
February 12, 2009
The prospect of wireless-enabled implants that ensure timely and correct dosages of medicine for those unable to care for themselves is fast approaching clinical reality but according to some researchers, the safety and security of these remote intelligent drug delivery systems (RIDDS) still need to be worked out. YanYan Wang and Carey Thaldorf at the University of Central Florida, in Orlando,...